Share Success: Letters From Readers
I: From Glenn K.
at Testimonial Submit Form Thursday, October 27, 2016 at 13:30:28
Hi, my name is Glenn K. I'm just shy of 64 and a few months ago developed a heel spur in my left foot.
Well, if you've ever had one, you know the pain I'm talking about. Get up first thing in
the morning, you can't walk. Sit for a while and get up, you can't walk. I had to cancel obligations and didn't know what to do.
My marketplace deductible this year is $6000. and since I hadn't used any going to a doctor wasn't my first choice. So I searched the net for any and everything related to heel pain. I came upon the EZorb website, read everything related, and ordered a three month supply of the powder.
I have since double dosed (recommended) for close to a month. My heel pain has been 80% reduced and I can now easily walk, even when first getting up. I did stop walking barefoot except for a few minutes or two; I think this helps also.
I truly believe within the next month, with EZorb, I can get back into an extended walking regime which will help me lose weight and further reduce any pain I am experiencing.
On a different note: on my other foot my big toe has for years given me a lingering pain. Constant, but bearable. I had no idea what was causing it since I never sought medical treatment. It is now completely gone. Coincidence? I don't think so.
All I can say is thank you!
II: From Joyce P.
Received at Testimonial Submit Form Wednesday, August 10, 2016 2:10 PM
I just wanted to tell you this. Couple of days ago my doctor told me my cholesterol went down from 270 two years ago to 210. He kept asking me what I'd been taking. I didn't have an answer for him because I totally forgot about the Marvlix I've been taking.
I realized it was Marvlix when I got home. Silly me - I've been taking 5 Marvlix a day for the past two years. I called my doctor immediately and he's very interested and said he would definitely look into it.
Thank you so much!
the Desk of EZorb Newsletter Editor:
newsletter is now read by over 95,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ ezorbonline.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public. If your testimonial is selected for publication, you will receive a generous gift to show our appreciation of your effort.
Research News: Race May Impact AF Outcome
Black individuals with atrial fibrillation (AF) have markedly higher rates of stroke, heart failure, coronary heart disease (CHD) and mortality than their White counterparts, data from the Atherosclerosis Risk in Communities (ARIC) study show.
These findings "have important public health implications", say Jared Magnani (University of Pittsburgh, Pennsylvania, USA) and co-authors.
These include an urgent "need to bolster prevention of adverse outcomes in black individuals with AF", as well as improving AF prevention in Black individuals overall in order to avoid the high social and medical costs of the associated morbidity, they say.
During a mean follow-up period of 20.6 years, Magnani and team identified 2348 cases of incident AF in 15,080 participants (mean age 54.2 years; 55% women; 25% Black individuals) of the ARIC study.
And although the incidence of AF was higher in White individuals than Black individuals, at 8.1 versus 5.8 cases per 1000 person-years, the rates of stroke, heart failure, CHD and mortality were higher in Black than White individuals, whether they had AF or not.
To assess the impact of AF on the absolute risk of each of these outcomes, the researchers calculated the rate difference per 1000 person-years between those with and without AF.
For stroke, the rate difference was 10.2 in White individuals and 21.4 in Black individuals. It was 71.8 and 101.4, respectively, for heart failure, and 25.6 and 44.9, respectively, for CHD. For all-cause mortality, White individuals had a rate difference of 55.9 compared with 106.0 for Black individuals.
This indicates "that black ARIC Study participants with AF are at considerably greater risk for associated adverse outcomes than white individuals with AF", Magnani and co-authors remark in JAMA Cardiology.
A second JAMA Cardiology study, published at the same time, used data on more than 17,000 people to investigate whether genetic variants account for racial differences in the risk of AF.
Gregory Marcus (University of California, San Francisco, USA) and colleagues identified one single nucleotide polymorphism (SNP) that accounted for between 11% and 32% of the reduced AF risk among Black individuals compared with White individuals.
Since this proportion was "modest", and no other SNPs were identified by genome-wide admixture mapping, Marcus et al suggest that "additional genetic or environmental influences beyond single SNPs in isolation may account for the paradoxical racial risk of AF among white individuals and black individuals."
Editorialists Thomas Stamos and Dawood Darber, from the University of Illinois at Chicago, USA, say that both studies "highlight the need for additional investigation regarding the possible social, environmental, and genetic causes for their findings."
Original research was published in 6-24-2016/Arrhythmia/News/Article.
Asked Questions & Answers
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix.